loader

World Tenders & Procurement Opportunities

Germany - Conclusion of non-exclusive discount agreements in accordance with; §§ 130a Para. 8/130c Para. 1 SGB V on medicinal products with the active ingredient certolizumab pegol (L04AB05) as part of an open house model. - Pharmaceutical products

World Biggest Tenders Source

This tender with title Germany - Conclusion of non-exclusive discount agreements in accordance with; §§ 130a Para. 8/130c Para. 1 SGB V on medicinal products with the active ingredient certolizumab pegol (L04AB05) as part of an open house model. - Pharmaceutical products has been published on Bidding Source portal dated 20 Mar 2023 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

General Information

Germany - Conclusion of non-exclusive discount agreements in accordance with; §§ 130a Para. 8/130c Para. 1 SGB V on medicinal products with the active ingredient certolizumab pegol (L04AB05) as part of an open house model. - Pharmaceutical products
Invitation for Bids
2023/S 055-158568
Germany
Germany-Eisenberg
20 Mar 2023
28 Feb 2025
English
Pharmaceutical products

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

Pharmaceutical products – conclusion of non-exclusive discount agreements in accordance with Section 130a Paragraph 8 SGB V for the active ingredients mentioned with the possibility of conclusion within the framework of the so-called open house procedure. - 240226-2024 Germany Pharmaceutical products – 31. Generikaausschreibung (1a) - 238051-2024 Germany Pharmaceutical products – GWQ - Methocarbamol (i.v. und FTA 12 St) - 239930-2024 Germany Pharmaceutical products – Drug tender_2024 a - 240617-2024 Germany Pharmaceutical products – 31. Generikaausschreibung (1b) - 235137-2024 Germany Pharmaceutical products – Open house drug discount agreements Interferon beta-1a, finished drug name Avonex, ATC L03AB07 - 224063-2024 Germany Pharmaceutical products – Open house drug discount agreements Vilanterol and umeclidinium bromide, ATC R03AL03 - 224747-2024 Germany Pharmaceutical products – conclusion of a non-exclusive Discount agreement according to Section 130a paragraph 8 or 130c paragraph 1 SGB V for the period from June 1st, 2024 to usually May 31st, 2026 - 227152-2024 Germany Pharmaceutical products - Conclusion of non-exclusive discount agreements in accordance with Sections 130a Paragraph 8/130c Paragraph 1 SGB V for medicines with the active ingredient melatonin (N05CH01), excluding prolonged-release tablets with an effective strength of 2mg as part of a so-called open-house model. - 224643-2024 Germany Pharmaceutical products - Conclusion of non-exclusive discount agreements in accordance with Sections 130a Paragraph 8/130c Paragraph 1 SGB V for medicines with the active ingredients timolol and brinzolamide (S01ED67) as part of a so-called open house model. - 223838-2024 Germany
No. 12, 1 st floor, Block B2, EGS Business Park, World Trade Center, Bakirkoy - Istanbul - Turkey
info@biddingsource.com
24 X 7 online support
TOP
For viewing latest tenders published for your business in all over the World: Sign in Join free
For accessing full details of Tenders, Kindly choose the Plan that works for you: View Subscription Plans